Zacks missile-defense article restates known MFC momentum; no new information to shift LMT thesis

What happened

A Zacks article dated September 23, 2026, highlights Lockheed's MFC segment gaining momentum from PAC-3, THAAD, and PrSM volumes lifting sales, profit, and backlog, but this simply restates what the company disclosed in its Q2 2026 10-Q. The DeepValue report already captures that MFC backlog surged to $87.9 billion and margin improved to 14.5% in Q2, driven by those same programs. However, the stock's $582.6 price on July 24 already reflects much of the missile story at 21.4x earnings and 19.5x EV/EBITDA, and the key catalysts—funded PAC-3 initial awards and no new Aeronautics charges—remain unconfirmed. The article does not address the concentration risk in THAAD backlog or the $125 million F-16 and $95 million C-130 profit adjustments that eroded first-half results. Therefore, the news adds no incremental evidence to shift the risk-reward, and investors should not treat it as a new signal.

Implication

The missile momentum is real, but the stock already prices in much of the upside. Investors should wait for either a pullback toward the $545 attractive entry or concrete evidence that funded PAC-3 awards are converting and Aeronautics charges have stopped. Until then, the asymmetry is limited because failure to secure funding or renewed execution issues could trigger a re-rating down to the bear scenario of $515. A patient, data-driven approach is warranted.

Thesis delta

The digest does not alter the investment thesis; LMT remains a WAIT. The article's focus on MFC momentum is already incorporated in the base case, and it fails to address the bear case's key triggers. No shift in conviction or price targets.